Drug details
Prevnar 13 (pneumococcal 13-valent conjugate vaccine [diphtheria crm197 protein] suspension for intramuscular injection)
type of Vaccines, Inactivated, Bacterial
Prevnar 13 (Pneumococcal 13-valent conjugate vaccine [diphtheria CRM197 protein]) suspension for intramuscular injection is indicated for active immunization for the prevention of disease caused by Streptococcus pneumoniae. In adults 50 years and older, Prevnar 13 is used to immunize against pneumococcal pneumonia and invasive disease. In adults, antibody responses to Prevnar 13 were diminished when given with inactivated Influenza Virus Vaccine. In children 6 weeks through 5 years of age, Prevnar 13 is used to immunize against invasive pneumococcal disease and otitis media.
The drug is often used to treat Pneumonia .
This drug may have the following side effects:
- headache,
- vomiting,
- skin rash,
- joint pain,
- chills,
- drowsiness,
- muscle pain,
- fatigue,
- tired feeling,
- diarrhea, or
- decreased appetite,
- injection site reactions (pain, redness, swelling, tenderness, or a hard lump),
- limitation of arm movement,
- sleeping more or less than usual,
- low grade fever (102 degrees or less).
The following drugs are related to Prevnar 13, either as a replacement or used together:
- Coly-Mycin M (colistimethate injection)
- Vaxneuvance (pneumococcal 15-valent conjugate vaccine for injection)
- Prevnar 20 (pneumococcal 20-valent conjugate vaccine for injection)
- Prevnar (pneumococcal 7-valent conjugate)
- Pneumovax 23 (pneumococcal vaccine polyvalent)